ELEVATION ONCOLOGY
Elevation Oncology makes genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of disease. Its lead candidate, seribantumab, which inhibits tumor growth driven by NRG1 fusions, is currently being clinically tested in the Phase 2 CRESTONE study for patients with tumors of any origin that have an NRG1 fusion.
ELEVATION ONCOLOGY
Industry:
Biopharma Biotechnology Health Care Life Science Pharmaceutical
Founded:
2019-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.elevationoncology.com
Total Employee:
11+
Status:
Active
Contact:
(716) 371-1125
Email Addresses:
[email protected]
Total Funding:
147.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Alto Neuroscience
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Elpiscience Biopharmaceuticals
Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Resilience
Resilience provides end-to-end biopharmaceutical manufacturing and development solutions.
Roivant Sciences
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
K2 HealthVentures
K2 HealthVentures investment in Post-IPO Debt - Elevation Oncology
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Elevation Oncology
venBio Partners
venBio Partners investment in Series B - Elevation Oncology
Qiming Venture Partners USA
Qiming Venture Partners USA investment in Series B - Elevation Oncology
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Elevation Oncology
Aisling Capital
Aisling Capital investment in Series B - Elevation Oncology
Driehaus Capital Management
Driehaus Capital Management investment in Series B - Elevation Oncology
Samsara BioCapital
Samsara BioCapital investment in Series B - Elevation Oncology
BVF Partners
BVF Partners investment in Series B - Elevation Oncology
Vivo Capital
Vivo Capital investment in Series B - Elevation Oncology
Key Employee Changes
Official Site Inspections
http://www.elevationoncology.com Semrush global rank: 2.2 M Semrush visits lastest month: 8.87 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Elevation Oncology"
About Us - Elevation Oncology
Tammy Furlong is the Chief Financial Officer at Elevation Oncology, responsible for the financial oversight, management and compliance of the organization. Prior to becoming CFO, she …See details»
Elevation Oncology - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (716) 371-1125 Elevation Oncology makes genomic tests actionable by selectively developing drugs to inhibit the specific …See details»
Elevation Oncology Corporate Overview
Feb 22, 2021 We believe that every patient deserves to know what is driving their cancer and which therapeutics can treat it.See details»
Elevation Oncology - LinkedIn
Elevation Oncology is an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with …See details»
Elevation Oncology | Our Team
Newsroom Keep up with our latest news.; Publications Learn more about our science.; Trail Notes Insights from our leadership team; Cliffs Notes Downloadable, infographics and more.See details»
Elevation Oncology | Investor Overview
Dec 12, 2024 For more information, visit www.ElevationOncology.com. Stock Information. Change. Volume. Market Cap. Stock Information. NASDAQ ELEV. Stock Information. Latest news & updates. News Releases; Events & …See details»
Elevation Oncology Company Profile - Office Locations ... - Craft
Oct 29, 2024 Elevation Oncology has 1 employees at their 1 location. See insights on Elevation Oncology including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Elevation Oncology Company Overview, Contact Details
Jun 8, 2023 Cutting-Edge Cancer Therapies Elevation Oncology specializes in innovative selective cancer therapies targeting specific tumor characteristics, presenting a unique selling …See details»
Browse our latest resources - Elevation Oncology …
Sep 3, 2024 A live webcast and replay of the event will be available on the Events page of the Company's Investor Relations website at https://investors.elevationoncology.com. About Elevation Oncology, Inc. …See details»
Home - Elevation Oncology
Our vision is a future in which each tumor’s unique genomic test result can be matched with a purpose-built precision medicine. Together with our drug and diagnostic developer peers, we work to enable a personalized treatment plan …See details»
Elevation Oncology | News Releases
Jun 15, 2021 For more information visit www.ElevationOncology.com. ### Caris Life Sciences Business Development Contact: Brian D. Lamon, Ph.D. Chief Business Officer +1 (609) 955 …See details»
Our Focus Landing Page - Elevation Oncology
Elevation Oncology invests in four key areas of focus that together enable the elevation of precision medicine to the forefront of every cancer treatment journey:See details»
Browse our latest resources - investors.elevationoncology.com
Sep 23, 2024 For more information, visit www.ElevationOncology.com. Forward-Looking Statements. This press release contains forward-looking statements within the meaning of the …See details»
Careers - Elevation Oncology
If you share our beliefs and are interested in helping to further our mission, start by checking out our currently available positions below to see if any of them are a good fit. If they’re not quite …See details»
Browse our latest resources - investors.elevationoncology.com
Nov 6, 2024 For more information, visit www.ElevationOncology.com. Forward-Looking Statements . This press release contains forward-looking statements within the meaning of the …See details»
Newsroom Archives - Elevation Oncology
Elevation Oncology Expands Pipeline through Exclusive Licensing of EO-3021 (SYSA1801), a Clinical Stage Anti-Claudin18.2 Antibody Drug Conjugate, From CSPC Pharmaceutical GroupSee details»
Elevation Oncology | News Releases
Dec 12, 2024 Elevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno …See details»